ALZpath, Inc.

SEC filing

Biotechnology · Carlsbad, CA

Form D on EDGAR

Amount raised$8.4Msold at filing

Total offering$10.4M$2M still open

Investors in the raise8count reported to the SEC

FiledJul 21, 2026first sale Jul 14, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Samantha Budd HaeberleinDirector

Michael BanvilleExecutive Officer, Promoter

Harry JohnsDirector

John CourtneyDirector

John HensingDirector

Irit RappleyDirector

Jerre SteadDirector

Executive officers, directors and promoters as listed on the Form D.